These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 37109520)
1. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis. Maccauro V; Airola C; Santopaolo F; Gasbarrini A; Ponziani FR; Pompili M Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109520 [TBL] [Abstract][Full Text] [Related]
2. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640 [TBL] [Abstract][Full Text] [Related]
3. Alterations of gut microbiota in cirrhotic patients with spontaneous bacterial peritonitis: A distinctive diagnostic feature. Zhou Z; Lv H; Lv J; Shi Y; Huang H; Chen L; Shi D Front Cell Infect Microbiol; 2022; 12():999418. PubMed ID: 36147601 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-related complications in cirrhosis. Gómez-Hurtado I; Such J; Sanz Y; Francés R World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446 [TBL] [Abstract][Full Text] [Related]
7. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis. Dănulescu RM; Stanciu C; Trifan A Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694 [TBL] [Abstract][Full Text] [Related]
8. The role of rifaximine in the prevention of the spontaneous bacterial peritonitis. Dănulescu RM; Ciobică A; Stanciu C; Trifan A Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):315-20. PubMed ID: 24340510 [TBL] [Abstract][Full Text] [Related]
15. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. Nicoletti A; Ponziani FR; Biolato M; Valenza V; Marrone G; Sganga G; Gasbarrini A; Miele L; Grieco A World J Gastroenterol; 2019 Sep; 25(33):4814-4834. PubMed ID: 31543676 [TBL] [Abstract][Full Text] [Related]
16. The influence of antibiotic treatment on the dynamics of oxidative stress in spontaneous bacterial peritonitis. Dănulescu RM; Ciobică A; Stanciu C; Trifan A Rev Med Chir Soc Med Nat Iasi; 2013; 117(3):598-604. PubMed ID: 24502022 [TBL] [Abstract][Full Text] [Related]
17. [Spontaneous and secondary bacterial peritonitis in cirrhotic patients with ascites]. Bruns T; Stallmach A Zentralbl Chir; 2014 Apr; 139(2):160-7. PubMed ID: 22144140 [TBL] [Abstract][Full Text] [Related]
18. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238 [TBL] [Abstract][Full Text] [Related]
19. Serum and ascitic fluid interleukin-17 in spontaneous bacterial peritonitis in Egyptian patients with HCV-related liver cirrhosis. Keryakos HKH; Mohammed AA; Higazi AM; Mahmoud EAM; Saad ZM Curr Res Transl Med; 2020 Nov; 68(4):237-243. PubMed ID: 32620468 [TBL] [Abstract][Full Text] [Related]